Multiplicity of benign breast disease lesions and breast cancer risk in African American women

• Published in: Frontiers in oncology Vol. 14; p. 1410819
• Main Authors: Patil, Vidya, Ruterbusch, Julie J, Chen, Wei, Boerner, Julie L, Abdulfatah, Eman, Alosh, Baraa, Pardeshi, Visakha, Shaik, Asra N, Bandyopadhyay, Sudeshna, Ali-Fehmi, Rouba, Cote, Michele L
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 16.05.2024
• Subjects: African American; benign breast disease; breast biopsy; breast cancer; hyperplasia; Oncology; breast cancer; hyperplasia; benign breast disease; breast biopsy; African American
• ISSN: 2234-943X; 2234-943X
• DOI: 10.3389/fonc.2024.1410819

The risk of developing subsequent breast cancer is higher in women diagnosed with benign breast disease (BBD) but these studies were primarily performed in non-Hispanic white populations. Still, these estimates have been used to inform breast cancer risk models that are being used clinically across all racial and ethnic groups. Given the high breast cancer mortality rates among African American (AA) women, it is critical to study BBD in this population, to ensure the risk models that include this information perform adequately. This study utilized data from AA women who underwent benign breast biopsies at a hospital served by the University Pathology Group in Detroit, Michigan, from 1998 to 2010. Patients were followed for subsequent breast cancers through the population-based Metropolitan Detroit Cancer Surveillance System (MDCSS). BBD lesion scores were assigned to represent the severity or extent of benign breast lesions, with higher scores indicating a greater number of distinct lesion types. Of 3,461 eligible AA women with BBD in the cohort, 6.88% (n=238) subsequently developed breast cancer. Examined individually, six of the eleven lesions (apocrine metaplasia, ductal hyperplasia, lobular hyperplasia, intraductal papilloma, sclerosing adenosis, columnar alterations and radial scars) were significantly associated with increased risk of breast cancer after adjustment for age and year of biopsy and were further considered in multiple lesion models. For every different type of benign breast lesion, subsequent risk of breast cancer increased by 25% (RR=1.25, 95% CI: 1.10, 1.42) after adjustment for age at biopsy and proliferative versus non-proliferative disease. In summary, this study affirms the increased breast cancer risk in AA women with BBD, particularly in those with multiple lesions. These findings have implications for the management of breast cancer risk in millions of women affected by BBD, a high risk group that could benefit from personalized surveillance and risk reduction strategies.